Literature DB >> 17406322

Clinical and empirical applications of the Rey-Osterrieth Complex Figure Test.

Min-Sup Shin1, Sun-Young Park, Se-Ran Park, Soon-Ho Seol, Jun Soo Kwon.   

Abstract

The Rey-Osterrieth Complex Figure Test (ROCF), which was developed by Rey in 1941 and standardized by Osterrieth in 1944, is a widely used neuropsychological test for the evaluation of visuospatial constructional ability and visual memory. Recently, the ROCF has been a useful tool for measuring executive function that is mediated by the prefrontal lobe. The ROCF consists of three test conditions: Copy, Immediate Recall and Delayed Recall. At the first step, subjects are given the ROCF stimulus card, and then asked to draw the same figure. Subsequently, they are instructed to draw what they remembered. Then, after a delay of 30 min, they are required to draw the same figure once again. The anticipated results vary according to the scoring system used, but commonly include scores related to location, accuracy and organization. Each condition of the ROCF takes 10 min to complete and the overall time of completion is about 30 min.

Entities:  

Mesh:

Year:  2006        PMID: 17406322     DOI: 10.1038/nprot.2006.115

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  149 in total

1.  Evaluation of Surgical Dexterity During the Interview Day: Another Factor for Consideration.

Authors:  Dinchen Jardine; Benjamin Hoagland; Angel Perez; Eric Gessler
Journal:  J Grad Med Educ       Date:  2015-06

Review 2.  Visual processing in anorexia nervosa and body dysmorphic disorder: similarities, differences, and future research directions.

Authors:  Sarah K Madsen; Cara Bohon; Jamie D Feusner
Journal:  J Psychiatr Res       Date:  2013-06-27       Impact factor: 4.791

3.  Non-verbal memory measured by Rey-Osterrieth Complex Figure B: normative data.

Authors:  Simona Luzzi; Martina Pesallaccia; Katia Fabi; Marco Muti; Giovanna Viticchi; Leandro Provinciali; Massimo Piccirilli
Journal:  Neurol Sci       Date:  2011-06-01       Impact factor: 3.307

4.  The neuropsychological correlates of pathological lying: evidence from behavioral variant frontotemporal dementia.

Authors:  Michele Poletti; Paolo Borelli; Ubaldo Bonuccelli
Journal:  J Neurol       Date:  2011-04-22       Impact factor: 4.849

5.  Altered Neurochemistry in Former Professional Soccer Players without a History of Concussion.

Authors:  Inga K Koerte; Alexander P Lin; Marc Muehlmann; Sai Merugumala; Huijun Liao; Tyler Starr; David Kaufmann; Michael Mayinger; Denise Steffinger; Barbara Fisch; Susanne Karch; Florian Heinen; Birgit Ertl-Wagner; Maximilian Reiser; Robert A Stern; Ross Zafonte; Martha E Shenton
Journal:  J Neurotrauma       Date:  2015-05-14       Impact factor: 5.269

6.  Functional neural substrates of posterior cortical atrophy patients.

Authors:  H Shames; N Raz; Netta Levin
Journal:  J Neurol       Date:  2015-05-16       Impact factor: 4.849

7.  Early Initiation of Amphetamine-Type Stimulants (ATS) Use Associated with Lowered Cognitive Performance among Individuals with Co-Occurring Opioid and ATS Use Disorders in Malaysia.

Authors:  Weng-Tink Chooi; Norzarina Mohd Zaharim; Alethea Desrosiers; Imran Ahmad; Mohd Azhar Mohd Yasin; Sharifah Z Syed Jaapar; Richard S Schottenfeld; Balasingam K Vicknasingam; Marek C Chawarski
Journal:  J Psychoactive Drugs       Date:  2017-06-29

8.  Cognitive Contributions to Freezing of Gait in Parkinson Disease: Implications for Physical Rehabilitation.

Authors:  Daniel S Peterson; Laurie A King; Rajal G Cohen; Fay B Horak
Journal:  Phys Ther       Date:  2015-09-17

9.  An Ultraconserved Brain-Specific Enhancer Within ADGRL3 (LPHN3) Underpins Attention-Deficit/Hyperactivity Disorder Susceptibility.

Authors:  Ariel F Martinez; Yu Abe; Sungkook Hong; Kevin Molyneux; David Yarnell; Heiko Löhr; Wolfgang Driever; Maria T Acosta; Mauricio Arcos-Burgos; Maximilian Muenke
Journal:  Biol Psychiatry       Date:  2016-07-14       Impact factor: 13.382

10.  Structural explanation of poor prognosis of amyotrophic lateral sclerosis in the non-demented state.

Authors:  H-J Kim; S-I Oh; M de Leon; X Wang; K-W Oh; J-S Park; A Deshpande; M Buj; S H Kim
Journal:  Eur J Neurol       Date:  2016-10-18       Impact factor: 6.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.